Introducing our new arrivals

This post is 11 years old, so some information may be outdated

The Cancer Research UK family just got a little bigger. And we’d like to share our happy news with you.

Labour pains began a few months ago when one of our funding committees (the Training and Career Development Board) was tasked with trawling through nearly one hundred grant applications to find the UK’s brightest and most creative scientific minds.

And after four exhausting days, 12 fledgling scientists were delivered to the cancer research community – nine boys and three girls – collective weight approximately 1818lb 13oz.

Cancer Research UK and the ‘little ones’ are all doing well. The below slideshow gives some details about their work:

: Dr Doryen Bubeck is studying ways to boost the immune system to fight cancer

: Dr Dragana Ahel is working out how cells repair damage to their DNA

: Dr Ferdia Gallagher is changing the way we look at ovarian cancer

: Dr Giacomo De Piccolo is hunting down molecules involved in cell division

: Dr Juan Carlos Acosta wants to know how the cells surrounding a tumour propel its growth

: Dr Nicholas Turner is looking at the way signalling pathways misbehave in cancer

: Dr Oliver Florey is investigating how cells recycle their components and how this is involved in cancer

: Dr Sarah Bohndiek is investigating a new type of imaging to see if it can help detect cancer earlier and give a more accurate picture of how people are responding to treatment

: Dr Sebastian Guettler is studying a molecule called Tankyrase, a very promising potential target for new cancer drugs

: Dr Simon Buczacki is finding out how cancer stem cells fuel drug resistance in bowel cancer

: Dr Simon Leedham is dissecting the molecules involved in bowel cancer

: Dr Ultan McDermott is trying to find out why tumours become resistant to treatment

Investing in new talent maintains a flow of new ideas and keeps cancer research fresh and invigorated.

Like all our researchers, our new arrivals carry the hopes of hundreds of thousands of cancer patients on their shoulders. To meet this incredible challenge – we’ve invested over £8m towards helping them, so that they can help all of us.

We’d like to welcome them to the family and we wish them success in their research.

Comments

RobbieW

13 September 2013

I wish them the best of luck.

Have you told them about your policy on e-cigs though?. Probably the biggest public health prize in a generation with the potential to almost eliminate smoking related cancers.

Do your new starts know that CRUK support a policy which is essentailly a de-facto ban.

Careful new starts, being associatsed with CRUK and their repidly diminising reputation may be harmful to your career.
Rebecca

12 September 2013

Go for it and all the best of luck you clever lot! xxx

Comments

RobbieW

13 September 2013

I wish them the best of luck.

Have you told them about your policy on e-cigs though?. Probably the biggest public health prize in a generation with the potential to almost eliminate smoking related cancers.

Do your new starts know that CRUK support a policy which is essentailly a de-facto ban.

Careful new starts, being associatsed with CRUK and their repidly diminising reputation may be harmful to your career.
Rebecca

12 September 2013

Go for it and all the best of luck you clever lot! xxx

Cancer News

Comments

Highlighted content

The mysterious stem cells that could hold the key to beating bowel cancer

Partnering olaparib with chemotherapy helps treat BRCA breast cancers

"What changed when I was diagnosed with cancer"

Scientists develop a 'metal detector' to find cancer's weak points

E. coli toxin could be linked to rising rates of bowel cancer in younger adults

Let's talk about poo

Bowel cancer awareness month: Common questions answered

The myth of the battle - can the way we talk about cancer change the way we interact with the disease?

More like this

Enhanced breast cancer screening could help more women with dense breasts

20 years in partnership with TK Maxx: How a dress celebrates £50m raised for vital cancer research

Partnering olaparib with chemotherapy helps treat BRCA breast cancers

Comments

Cancer News

Introducing our new arrivals

Comments

Highlighted content

More like this

Related topics

Sign up to our newsletter

Comments